Abbott Laboratories (ABT)
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Abbott Labs: Proactive, Adaptive, Solid
Abbott's proactive leadership and diversified business model help it navigate macro challenges and market volatility effectively. Strong Q1 performance in Nutrition, Medical Devices, and Vascular segments offsets weakness in Diagnostics and China sales, showcasing resilience and adaptability. Management's focus on gross margin expansion, cost-saving initiatives, and shareholder-friendly policies like dividend increases support long-term value.
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
In the closing of the recent trading day, Abbott (ABT) stood at $133.67, denoting a -2.71% move from the preceding trading day.
Best Dividend Kings: June 2025
Dividend Kings have underperformed the S&P 500 year-to-date, but 26 are outperforming SPY in 2025, with 32 posting positive returns. Dividend growth remains healthy, with four recent increases and a collective 2025 growth rate of 5.19%, despite some downward earnings revisions. Seventeen Dividend Kings appear undervalued and offer long-term annualized expected returns of at least 10%, based on Dividend Yield Theory analysis.
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
ABT's i-STAT TBI Test Receives Approval in Canada: Stock to Rise?
Abbott gains Health Canada approval for its i-STAT TBI test, enabling rapid bedside concussion detection via whole blood.
Abbott (ABT) Stock Dips While Market Gains: Key Facts
In the most recent trading session, Abbott (ABT) closed at $134.01, indicating a -1.19% shift from the previous trading day.
5 Dividend Kings Are Delivering Massive Total Returns of Up to 34% This Year
Investors love dividend stocks because they provide dependable passive income streams and an excellent opportunity for solid total return.
5 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
Volatility is a part of life for long-term investors. The reasons the market goes up or down change, but the constant is that high-quality stocks, businesses that increasingly make more money over time, will reward investors if you wait long enough.
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note
Abbott (ABT) closed at $132.96 in the latest trading session, marking a -0.56% move from the prior day.
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
